Helius Medical Technologies Inc - Ordinary Shares - Class A
HSDT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$147.09M
Close$
$-2.15
224.4% downside
Current Fair Value
224.4% downsideOvervalued by 224.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $147.09 Million |
|---|---|
| Enterprise Value | $145.96 Million |
| Earnings per Share | $-1.85 |
| Beta | 1.07 |
| Outstanding Shares | 85,021,721 |
Return
| Return on Equity | 112.93% |
|---|---|
| Return on Assets | 102.74% |
| Return on Invested Capital | 72.72% |
Valuation & Multiples
| P/E Ratio | 0.46 |
|---|---|
| PEG | -0.35 |
| Price to Sales | - |
| Price to Book Ratio | 0.58 |
| Enterprise Value to Revenue | 9.91 |
| Enterprise Value to EBIT | 0.73 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 11, 2026
EPS
$1.17
Est. -$0.01Revenue
$3.36 M
Est. $2.85 MNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
-$0.01
Consensus analyst estimateRevenue Estimate
$3.35 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 17.70% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.38%▼ 18.77% |
|---|---|
| Total Invested | $2.83M▼ 89.11% |
| Investors Holding | 5▼ 40.00% |
About Helius Medical Technologies Inc
19 employees
CEO: Philippe Deschamps
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. ...